Posted by Michael Wonder on 02 Aug 2018
Amid EpiPen shortage, a Canadian-based company has approval for an alternative
1 August 2018 - Bausch Health says it is 'actively seeking' to bring anaphylaxis injector to Canadian patients.
EpiPen, made by Pfizer, is the only epinephrine auto-injector available to Canadians to stop a life-threatening anaphylactic reaction. Health Canada says it has approved similar medications from other companies, but they have not yet decided to start manufacturing in this country.
As a worsening EpiPen shortage prompts questions about why Canada relies on just one pharmaceutical manufacturer to supply a life-saving treatment, a Laval, Que., drug company says it is "actively seeking" to bring another epinephrine self-injector that stops anaphylactic reactions to this country.
